Sector: Pharmaceuticals & Biotechnology

Small Cap

Nectar Lifesciences Share Price

Q: What is the current share price of Nectar Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Nectar Lifesciences Ltd. is ₹ 10.8 on the NSE and ₹ 10.79 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Nectar Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Nectar Lifesciences Ltd. is approximately ₹ 234.8 Cr.

Q: What are the PE and PB ratios for Nectar Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Nectar Lifesciences Ltd. is -1, and the Price-to-Book (PB) ratio is 0.4.

Q: What is the 52-Week High and Low for Nectar Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Nectar Lifesciences Ltd. shares was ₹ 22.4, and the lowest price was ₹ 9.3.

Q: Who are the major shareholders of Nectar Lifesciences Ltd.?

Significant shareholdings in Nectar Lifesciences Ltd. typically include entities such as: Promoter Public Other Institutions FII (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Nectar Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Nectar Lifesciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Q: What is the latest dividend information for Nectar Lifesciences Ltd.?

Nectar Lifesciences Ltd. last declared a FINAL dividend of ₹ 0.05 per share for the financial period ending 2020. The record date was set as 2020-09-11, and the payment was/is scheduled around 2020-09-11. For the most current dividend announcements, refer to official company filings.

NECLIFE

₹10.80

0.33(3.15%)

24th Aug 2026 | 3:28 PM

NSE : NECLIFE

Open Free Demat Account

Nectar Lifesciences Performance

Price Movement

₹10.80

₹10.48

₹10.84

↘ Today's Low↗ Today's High

1 Year Performance

₹10.80

₹9.30

₹22.40

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹10.84

Low₹10.48

Open at₹10.59

Prev Close₹10.47

Volumes1.64 L

Avg Price₹10.69

Lower Circuit₹9.43

Upper Circuit₹11.51

Historical Performance

3M High₹12.75

3M Low₹9.98

1 Yr High₹22.40

1 Yr Low₹9.30

3 Yr High₹56.50

3 Yr Low₹9.30

5 Yr High₹56.50

5 Yr Low₹9.30

Summary

As of 25-08-2026 02:00, Nectar Lifesciences Ltd. share price today is ₹0, with a change of ₹-10.47 (-100.00%) from the previous close of ₹10.47. The stock opened at ₹10.59 and traded between ₹10.48 and ₹10.84, with a total traded volume of 164365 shares. The company has a market capitalization of ₹234.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹22.4 and ₹9.3, respectively.

Nectar Lifesciences Ltd. valuation metrics include a P/E ratio of -1, EPS of ₹-13.4, and book value of ₹0.40. Profitability indicators show ROE of -50.29%. Nectar Lifesciences Ltd. has reported revenue of ₹5.44 Cr and net profit of ₹-245.06 Cr.

Nectar Lifesciences Ltd. technical indicators include Day RSI at 44.72, Day MFI at 39.92, Day ADX at 24.11. Additional indicators include Commodity Channel Index (CCI) at -38.4 and Williams %R at -73.75. Momentum indicators show Day MACD at -0.09, Day MACD Signal Line at -0.1, DayATR at 0.54. Rate of Change indicators for Nectar Lifesciences Ltd. include ROC125 at -20.5 and ROC21 at 1.06.

Exponential moving averages include EMA5 at ₹10.6, EMA10 at ₹10.6, EMA12 at ₹10.7, EMA20 at ₹10.7, EMA26 at ₹10.8, EMA50 at ₹11, EMA100 at ₹11.7, EMA200 at ₹13.5. Simple moving averages include SMA5 at ₹10.6, SMA10 at ₹10.7, SMA20 at ₹10.6, SMA30 at ₹10.6, SMA50 at ₹11, SMA100 at ₹11.5, SMA150 at ₹11.9, SMA200 at ₹13.4.

Support levels for Nectar Lifesciences are placed at First Support ₹10.05, Second Support ₹9.62, Third Support ₹9.20. Resistance levels are seen at First Resistance ₹10.90, Second Resistance ₹11.32, Third Resistance ₹11.75. Nectar Lifesciences Ltd. shareholding pattern shows promoter holding at 51.84%, FII holding at 0.5%, DII holding at 0%, public holding at 43.9%.

Nectar Lifesciences Fundamentals

Market Cap

Below industry Median

234.80 Cr.

PE Ratio (TTM)

Negative PE TTM

-1

Dividend Yield

Net Profit TTM

36% decr over last year

-245.06

Net Profit Growth

36% decr over last year

-245.06

PEG Ratio

Below industry Median

ROE

323% decr over last year

-50.29

Operating Revenue TTM

5.44

Operating Revenue Growth

100% decr over last year

Book Value

Low in industry

0.40

MFI

MFI is mid-range

39.92

RSI

RSI is mid-range

44.72

EPS (TTM)

-13.40

Debt to Equity

Face Value

Operating Profit Margin Qtr.

-653.34

Operating Profit Qtr.

-27.27

Net Profit Qtr.

-15.40

Operating Revenue Qtr.

0.44

PB Ratio

0.40

Nectar Lifesciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	0.44	0	0	5	280.67
Operating Expense	27.68	58.52	1.92	6.04	342.56
Operating Profit	-27.24	-58.52	-1.92	-1.04	-61.89
Depreciation	0.11	0.08	0.06	0.20	16.52
Interest	0.16	5.90	30.22	0	18.70
Tax	-8.20	-19.71	-11.02	-0.18	-33.52
Net Profit	-13.14	-67.92	14.27	-176.01	-63.23

Nectar Lifesciences Technicals

Nectar Lifesciences Ltd. EMA & SMA

₹10.80

0.51 (4.96%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹10.6

Day EMA10 ₹10.6

Day EMA12 ₹10.7

Day EMA20 ₹10.7

Day EMA26 ₹10.8

Day EMA50 ₹11

Day EMA100 ₹11.7

Day EMA200 ₹13.5

Nectar Lifesciences Support and Resistance

Resistance

First Resistance₹10.90

Second Resistance₹11.32

Third Resistance₹11.75

Support

First Support₹10.05

Second Support₹9.62

Third Support₹9.20

Technical Indicators

Day RSI44.72

Day MFI39.92

Day ADX24.11

Day Commodity Channel Index-38.40

William-73.75

Day MACD-0.09

Day MACD Signal Line-0.10

Day ATR0.54

Day ROC125-20.50

Day ROC211.06

Nectar Lifesciences Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	44.5	44.5	44.9	44.9	51.8	51.8
FII	1.6	0.8	0.6	0.5	0.6	0.5
DII	0.2	0.2	0.1	5.9	4	3.8
Public	53.6	54.4	54.4	48.7	43.5	43.9

Nectar Lifesciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.67 L	3.99 L	67.12%
Week	2.28 L	2.95 L	77.15%
1 Month	1.68 L	1.84 L	91.67%
6 Month	2.66 L	3.4 L	78.30%

Nectar Lifesciences SWOT Analysis

Strengths6

Weakness16

Opportunity1

Threats0

Companies with no Debt

PEG lower than Industry PEG

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Volume Shockers

Nectar Lifesciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
11 Sep, 2020	0.05	FINAL	Equity Share
19 Sep, 2019	0.05	FINAL	Equity Share
19 Sep, 2018	0.05	FINAL	Equity Share
20 Sep, 2017	0.05	FINAL	Equity Share
22 Sep, 2016	0.1	FINAL	Equity Share
22 Sep, 2015	0.1	FINAL	Equity Share
21 Aug, 2014	0.1	FINAL	Equity Share
19 Sep, 2013	0.1	FINAL	Equity Share
20 Sep, 2012	0.1	FINAL	Equity Share
21 Sep, 2011	0.1	FINAL	Equity Share

Nectar Lifesciences Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹526.25	₹6.55	₹205.20	₹15.46	₹518.70	₹100.52
% Change	-2.70%	4.97%	4.81%	8.26%	-3.29%	4.99%
Revenue TTM (₹ Cr)	₹526.28	₹69.99	₹291.17	₹226.23	₹511.48	₹305.93
Net Profit TTM (₹ Cr)	₹20.77	₹-176.47	₹14.68	₹31.63	₹53.97	₹16.01
PE TTM	115.10	-0.30	51.80	2.40	28.70	32.50
1 Year Return	37.97	524	55.39	56.92	-23.59	8.81
ROCE	3.56	-56.37	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 30.45

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 988.00

-0.56%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.00

-2.14%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 628.00

+1.80%

ZIMLAB

Zim Laboratories Ltd.

₹ 124.16

-0.70%

MEDICO

Medico Remedies Ltd.

₹ 42.09

-1.31%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 173.00

-0.31%

LASA

Lasa Supergenerics Ltd.

₹ 7.33

+1.81%

HALEOSLABS

Haleos Labs Ltd.

₹ 1500.00

+2.39%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 302.20

+0.73%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 322.00

+0.00%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.26

-3.96%

BROOKS

Brooks Laboratories Ltd.

₹ 61.70

+2.83%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2638.00

+0.05%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 254.55

+4.99%

ALPA

Alpa Laboratories Ltd.

₹ 61.20

-2.47%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 354.00

-0.73%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 30.44

+9.97%

INDOCO

Indoco Remedies Ltd.

₹ 220.00

-2.78%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 325.35

-1.29%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 612.00

-0.33%

PANACEABIO

Panacea Biotec Ltd.

₹ 406.50

-1.12%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 234.00

-4.31%

THEMISMED

Themis Medicare Ltd.

₹ 120.50

+13.53%

FAQ's on NECLIFE

What is the current share price of Nectar Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Nectar Lifesciences Ltd. is ₹ 10.8 on the NSE and ₹ 10.79 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Nectar Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Nectar Lifesciences Ltd. is approximately ₹ 234.8 Cr.

What are the PE and PB ratios for Nectar Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Nectar Lifesciences Ltd. is -1, and the Price-to-Book (PB) ratio is 0.4.

What is the 52-Week High and Low for Nectar Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Nectar Lifesciences Ltd. shares was ₹ 22.4, and the lowest price was ₹ 9.3.

Who are the major shareholders of Nectar Lifesciences Ltd.?

Significant shareholdings in Nectar Lifesciences Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Nectar Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Nectar Lifesciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Nectar Lifesciences Ltd.?

Nectar Lifesciences Ltd. last declared a FINAL dividend of ₹ 0.05 per share for the financial period ending 2020. The record date was set as 2020-09-11, and the payment was/is scheduled around 2020-09-11. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy